{"organizations": [], "uuid": "8937dc9aab96e53f0221bf4ae6562d70de03320c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-collegium-filed-patent-infringemen/brief-collegium-filed-patent-infringement-lawsuit-against-teva-pharma-usa-idUSFWN1QC187", "country": "US", "domain_rank": 408, "title": "BRIEF-Collegium Filed Patent Infringement Lawsuit Against Teva Pharma USA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T05:52:00.000+02:00", "replies_count": 0, "uuid": "8937dc9aab96e53f0221bf4ae6562d70de03320c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-collegium-filed-patent-infringemen/brief-collegium-filed-patent-infringement-lawsuit-against-teva-pharma-usa-idUSFWN1QC187", "ord_in_thread": 0, "title": "BRIEF-Collegium Filed Patent Infringement Lawsuit Against Teva Pharma USA", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "delaware", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "patent infringement lawsuit against teva pharma usa", "sentiment": "negative"}, {"name": "collegium pharmaceutical inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "teva pharmaceuticals usa inc", "sentiment": "none"}, {"name": "teva", "sentiment": "none"}, {"name": "collegium pharma", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Collegium Pharmaceutical Inc:\n* COLLEGIUM PHARMA SAYS FILED PATENT INFRINGEMENT LAWSUIT IN U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE AGAINST TEVA PHARMACEUTICALS USA INC\n* COLLEGIUM PHARMA SAYS LAWSUIT WAS FILED IN RESPONSE TO A PARAGRAPH IV CERTIFICATION CO RECEIVED FROM TEVA - SEC FILING\n* COLLEGIUM PHARMA SAYS CERTIFICATION STATED TEVA SUBMITTED ANDA TO U.S. FDA FOR GENERIC VERSION OF XTAMPZA ER (OXYCODONE) EXTENDED-RELEASE CAPSULES Source: ( bit.ly/2EVJmhH ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2EVJmhH"], "published": "2018-02-23T05:52:00.000+02:00", "crawled": "2018-02-23T15:45:58.000+02:00", "highlightTitle": ""}